Temozolomide as second or third line treatment of patients with neuroendocrine carcinomas

Ingrid Marie Holst Olsen, Jens B Sørensen, Birgitte Federspiel, Andreas Kjaer, Carsten P Hansen, Ulrich Knigge, Seppo W Langer

50 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Temozolomide as second or third line treatment of patients with neuroendocrine carcinomas'. Sammen danner de et unikt fingeraftryk.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience